Biosimilars: a cheaper and more effective alternative to brand-name drugs
The European Commission’s pharmaceutical reform will improve access to cheaper biosimilar medicines and speed up time to market. Connie Ziegler was diagnosed with rheumatoid arthritis when she was a child. “When I was about one and a half years old, my parents said that my knees in particular started to hurt. I didn’t want to … Read more
